PROBLEND Hand Sanitizer Recalled Due to Manufacturing Deficiencies
Seatex LLC is recalling PROBLEND Hand Sanitizer (Lot 266029) nationwide due to manufacturing deficiencies identified during FDA inspection.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This recall involves FDA Class II classification but lacks reported illnesses, injuries, or identified contamination. The basis is manufacturing process deviation without specific identified hazard or adverse health reports, consistent with precautionary recalls.
Plain-English summary
Seatex LLC is recalling PROBLEND Hand Sanitizer, a gel hand sanitizer containing 70% ethanol with mountain spring scent, sold in 1250 mL cases. The affected lot (266029, expiration 03/27/2024) was distributed nationwide throughout the United States and Puerto Rico.
The recall was initiated following an FDA inspection of Seatex's manufacturing facility, which identified deficiencies in Current Good Manufacturing Practice (CGMP) compliance. These manufacturing process deviations created a potential quality issue with the recalled product.
Consumers who have purchased this product should stop use of the affected lot and contact Seatex LLC for further instructions. Consumers who experience any adverse effects are encouraged to contact the FDA or the manufacturer.
The recalled product
- Product
- PROBLEND Hand Sanitizer, Refreshing Gel Hand Sanitizer, Ethanol 70% v/v Antiseptic, mountain spring scent, 1250 mL cases, Seatex LLC, 445 TX Hwy 36 Rosenberg, YX 77471
- Manufacturer
- Seatex LLC
- Category
- Drug — Topical Antiseptic
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 266029
- Exp. 03/27/2024.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27